A single microbubble formulation carrying 5-fluorouridine, Irinotecan and oxaliplatin to enable FOLFIRINOX treatment of pancreatic and colon cancer using ultrasound targeted microbubble destruction
Jinhui Gao, Keiran Logan, Heather Nesbitt, Bridgeen Callan, Thomas McKaig, Mark Taylor, Mark Love, A. P. McHale, Darren M. Griffith, John F. Callan
Topics & Concepts
FOLFIRINOXFolinic acidIrinotecanOxaliplatinMedicinePancreatic cancerColorectal cancerChemotherapyInternal medicineGemcitabineOncologyPharmacologyFluorouracilCancerUltrasound and Hyperthermia ApplicationsNanoparticle-Based Drug DeliveryHepatocellular Carcinoma Treatment and Prognosis